RALEIGH, N.C. (AP) — North Carolina will reap almost $16 million from a national Medicaid fraud settlement involving Abbott Laboratories.
|The state Attorney General's Office said Monday that's the state's portion of a $1.5 billion settlement with the company, Abbott agreed in federal court last week to settle claims over allegations that it promoted the anti-seizure drug Depakote for uses that the Food and Drug Administration hadn't approved.
|Depakote is an anti-seizure and mood-stabilizing drug prescribed for bipolar disorder. However, the company said it marketed the drug for unapproved uses, including treatment of schizophrenia, agitated dementia and autism.
|Of the $15.8 million paid to North Carolina, about $1 million will go to support public schools. The remainder will go to support Medicaid efforts in the state.
Complete your profile to continue reading and get FREE access to BenefitsPRO, part of your ALM digital membership.
Your access to unlimited BenefitsPRO content isn’t changing.
Once you are an ALM digital member, you’ll receive:
- Critical BenefitsPRO information including cutting edge post-reform success strategies, access to educational webcasts and videos, resources from industry leaders, and informative Newsletters.
- Exclusive discounts on ALM, BenefitsPRO magazine and BenefitsPRO.com events
- Access to other award-winning ALM websites including ThinkAdvisor.com and Law.com
Already have an account? Sign In
© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
